60 likes | 326 Views
Bio-Tech Sector Update. News & Headlines. Recent Activity & Numbers. In the News . EU Court Backs Generics And Deals Blow To AstraZeneca Eli Lilly and Company: Strattera Prescriptions Double in Three-Month Period GlaxoSmithKline Takes Further Action to Help the World's Poorest Fight HIV/AIDS.
E N D
Bio-Tech Sector Update News & Headlines
In the News • EU Court Backs Generics And Deals Blow To AstraZeneca • Eli Lilly and Company: Strattera Prescriptions Double in Three-Month Period • GlaxoSmithKline Takes Further Action to Help the World's Poorest Fight HIV/AIDS
3rd Quarter Profit Announcements • Decrease Schering-Plough- -66% AstraZeneca- -13% Eli Lilly expected to announce small loss • Increase Wyeth Profits- +28% Pfizer and GlaxoSmithKline also expected to announce increase in profits
Dividend Re-Investment Plan Also Known as DRIPs
Example • Suppose you have 1000 shares of JNJ at $50 dollars per share • You annually receive a $3 dollar per share dividend from JNJ which = $3000 • The Dividend Yield is 3/50=6% • In DRIPs you use the $3000 to buy 60 more shares of stock